Tetraphase Pharmaceuticals, Inc. (TTPH) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 37.2% since Nov 19, 2014.
The company has seen no estimate revisions over the past 7 days, while the Zacks Consensus Estimate remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Tetraphase Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.
Better-ranked players in the med-drugs industry include Biodel Inc. (BIOD), IGI, Laboratories, Inc. (IG) and Lannett Company, Inc. (LCI), all sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment